Virpax Pharmaceuticals Inc. (NASDAQ: VRPX)
$0.3660
+0.0004 ( -4.96% ) 593.7K
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.
Market Data
Open
$0.3660
Previous close
$0.3656
Volume
593.7K
Market cap
$5.44M
Day range
$0.3510 - $0.3940
52 week range
$0.2860 - $5.4800
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 13 | Sep 17, 2024 |
| 8-k | 8K-related | 15 | Aug 13, 2024 |
| 10-q | Quarterly Reports | 57 | Aug 12, 2024 |
| 8-k | 8K-related | 15 | Jul 30, 2024 |
| 8-k | 8K-related | 13 | Jul 26, 2024 |
| 8-k | 8K-related | 15 | Jul 24, 2024 |
| 3 | Insider transactions | 2 | Jul 15, 2024 |
| 8-k | 8K-related | 13 | Jul 15, 2024 |
| 4 | Insider transactions | 1 | Jul 10, 2024 |
| 8-k | 8K-related | 15 | Jul 10, 2024 |